C3D-binding assay for the detection of complement activating hla antibodies: A replacement for the CDC assay prior to donor allocation?

被引：0
|
作者：
Wong, Zo Ee [1 ]
Downing, Jonathan [1 ]
De Santis, Dianne [1 ]
Halse, Megan [2 ]
Bruce, Samuel [1 ]
Linh Truong [1 ]
Martinez, Patricia [2 ]
D'Orsogna, Lloyd [2 ]
机构：
[1] Fiona Stanley Hosp, PathWest, Murdoch, WA, Australia
[2] Univ Western Australia, Perth, WA, Australia
来源：
HLA | 2022年 / 99卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P7
引用
收藏
页码：452 / 453
页数：2
相关论文
共 50 条
  • [41] Role of Pretransplant Complement-fixing Donor-specific Antibodies Identified by C1q Assay in Kidney Transplantation
    Thammanichanond, D.
    Wiwattanathum, P.
    Mongkolsuk, T.
    Kantachuvesiri, S.
    Worawichawong, S.
    Vallipakorn, S. A.
    Kitpoka, P.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (03) : 756 - 760
  • [42] Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens
    Frank, Renee
    Lal, Priti
    Kearns, Jane
    Molina, Maria R.
    Wald, Joyce W.
    Goldberg, Lee R.
    Kamoun, Malek
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 145 (01) : 62 - 68
  • [43] Development of a novel ANTI-C3D fixation assay: a tool for predicting the relevance of Luminex detectable HLA antibodies in renal transplantation
    Percival, A.
    Sage, D. A.
    TISSUE ANTIGENS, 2011, 77 (05): : 446 - 447
  • [44] Is HLA Donor-Specific Antibody (DSA)-C3d+Assay a Potential Predictor of Subclinical Antibody Mediated Damage in the Renal Graft?
    Contreras, A. G.
    Solis-G, M. I.
    Ramirez-Espinoza, C.
    Hernandez-Rosales, J.
    Vilatoba-Chapa, M.
    Cruz-Martinez, R.
    Granados, J.
    Morales-Buenrostro, L. E.
    Alberu, J.
    Arreola-Guerra, J. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1070 - 1071
  • [45] COMPLEMENT FIXING DONOR-SPECIFIC ANTIBODIES IDENTIFIED BY THE C1q ASSAY IN COMBINED LIVER-KIDNEY TRANSPLANTS WITH AMR
    Askar, Medhat
    Kearns, Jane
    McCarro, Valerie
    Khan, Shahper
    Klingrman, Lynne
    Flechner, Stuart
    Fung, John
    Kamoun, Malek
    HUMAN IMMUNOLOGY, 2013, 74 : 54 - 54
  • [46] Trends in Immune Cell Function Assay and Donor-Specific HLA Antibodies in Kidney Transplantation: A 3-Year Prospective Study
    Libri, I.
    Gnappi, E.
    Zanelli, P.
    Reina, M.
    Giuliodori, S.
    Vaglio, A.
    Palmisano, A.
    Buzio, C.
    Riva, G.
    Barozzi, P.
    Luppi, M.
    Cravedi, P.
    Maggiore, U.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (12) : 3215 - 3222
  • [47] Qualification of a surface plasmon resonance assay to determine binding of IgG-type antibodies to complement component C1q
    Jovic, Milan
    Cymer, Florian
    BIOLOGICALS, 2019, 61 : 76 - 79
  • [48] Is C3d-fixing Donor Specific HLA Antibody Detection Really Necessary?
    Malvezzi, P.
    Villemaire, M.
    Bourdin, A.
    Jouve, T.
    Tetaz, R.
    Janbon, B.
    Terrier, N.
    Masson, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 345 - 345
  • [49] COMPLEMENT (C′)-BINDING ANTI-HLA DONOR SPECIFIC ANTIBODIES (DSA) IN HEART TRANSPLANTATION. CORRELATION WITH ANTIBODY MEDIATED REJECTION (AMR)
    Redonnet, M.
    Belin, A.
    Hau, F.
    Toutirais, O.
    Quelvennec, E.
    Le Mauf, B.
    Francois, A.
    Crahes, M.
    Galateau, M.
    Nafeh, C.
    Gay, A.
    Blanchart, K.
    Babtasi, G.
    Litzler, P. Y.
    Bessou, J. P.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 2 - 2
  • [50] Clinical Significance of C3d Assay in Kidney Transplant Recipients With Donor-Specific Anti-Human Leukocyte Antigen Antibodies
    Paek, Jin Hyuk
    Kwon, Jungheon
    Lim, Jimin
    Kim, Yaerim
    Park, Woo Yeong
    Jin, Kyubok
    Han, Seungyeup
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (02) : 341 - 345
12345